Bionano Genomics, Inc. — Director's Dealing 2022

Feb 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc. (BNGO)
CIK: 0001411690
Period of Report: 2022-02-17

Reporting Person: Rajkovic Aleksandar (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-17	Stock Option (right to buy)	$2.04	A	194986	Acquired	2032-02-17	Common Stock (194986)	Direct

Footnotes

F1: The shares vest in equal monthly installments over a three year period such that the option is fully vested on February 17, 2025, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).